2. Search Result
Search Result
Results for "

SB1317

" in MedChemExpress (MCE) Product Catalog:
Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-15166
    (E/Z)-Zotiraciclib
    5 Publications Verification

    (E/Z)-TG02; (E/Z)-SB1317

    		 CDK JAK FLT3 Cancer
    (E/Z)-Zotiraciclib ((E/Z)-TG02) is a potent inhibitor of CDK2, JAK2 and FLT3 with IC50s of 13, 73 and 56 nM, respectively. (E/Z)-Zotiraciclib effectively inhibits the proliferation of cancer cells, it can be used for the research of cancer .
    (E/Z)-Zotiraciclib
  • HY-15166A
    (E/Z)-Zotiraciclib hydrochloride
    5 Publications Verification

    (E/Z)-TG02 hydrochloride; (E/Z)-SB1317 hydrochloride

    		 CDK JAK FLT3 Cancer
    (E/Z)-Zotiraciclib ((E/Z)-TG02) hydrochloride is a potent CDK2, JAK2, and FLT3 inhibitor .
    (E/Z)-Zotiraciclib hydrochloride
  • HY-15166B
    (E/Z)-Zotiraciclib citrate
    5 Publications Verification

    (E/Z)-TG02 citrate; (E/Z)-SB1317 citrate

    		 CDK JAK FLT3 Cancer
    (E/Z)-Zotiraciclib citrate is a potent CDK2, JAK2, and FLT3 inhibitor .
    (E/Z)-Zotiraciclib citrate
  • HY-15163
    Zotiraciclib

    TG02; SB1317

    		 JAK CDK FLT3 Cancer
    Zotiraciclib (TG02) is an orally active potent inhibitor of CDK2, JAK2 and FLT3 with IC50 values of 13, 73, and 56 nM, respectively. Zotiraciclib can be used for the research of advanced leukemias and multiple myeloma .
    Zotiraciclib

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

  

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

  

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: